This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/530853-pfizer-moderna-vaccine-prices-eu/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Pfizer, Moderna, hike prices for their Covid jabs by up to a QUARTER for the EU – reports | Pfizer, Moderna, hike prices for their Covid jabs by up to a QUARTER for the EU – reports |
| (2 months later) | |
| Pfizer has reportedly raised the price of its Covid vaccine dose by a quarter, with Moderna also ramping up the price in its latest deal with the European Union. The two are making tens of billions of dollars in pandemic profits. | Pfizer has reportedly raised the price of its Covid vaccine dose by a quarter, with Moderna also ramping up the price in its latest deal with the European Union. The two are making tens of billions of dollars in pandemic profits. |
| According to the Financial Times, which has seen contracts between the two pharmaceutical companies and the EU, Pfizer's latest price for one vaccine dose was €19.50, or around $23 – up by four euro from the previous unit price of €15.50 euro. | According to the Financial Times, which has seen contracts between the two pharmaceutical companies and the EU, Pfizer's latest price for one vaccine dose was €19.50, or around $23 – up by four euro from the previous unit price of €15.50 euro. |
| Meanwhile, Moderna's latest price is around €21.50 ($25.50) per dose, up from the previous price of €19 ($22.60). Despite this, the Moderna price is still lower than previously expected – $28.50 – because of the EU purchasing more doses. | Meanwhile, Moderna's latest price is around €21.50 ($25.50) per dose, up from the previous price of €19 ($22.60). Despite this, the Moderna price is still lower than previously expected – $28.50 – because of the EU purchasing more doses. |
| Pfizer and Moderna – which earn a profit from the vaccines, unlike AstraZeneca, which is sold at cost – have pulled in tens of billions of dollars from the vaccines, with Pfizer forecasting $33.5 billion in revenue from its doses in this year alone. The forecast is up $7.5 billion from its previous prediction in the last quarter. | Pfizer and Moderna – which earn a profit from the vaccines, unlike AstraZeneca, which is sold at cost – have pulled in tens of billions of dollars from the vaccines, with Pfizer forecasting $33.5 billion in revenue from its doses in this year alone. The forecast is up $7.5 billion from its previous prediction in the last quarter. |
| Moderna, though behind Pfizer in sales, is forecasting $19.2 billion in Covid-19 vaccine revenue for 2021. | Moderna, though behind Pfizer in sales, is forecasting $19.2 billion in Covid-19 vaccine revenue for 2021. |
| Russia’s Sputnik V vaccine still hasn’t been approved by the European Medicines Agency (EMA) despite having been registered in 69 of the world's countries to date, including EU members Hungary and Slovakia. | Russia’s Sputnik V vaccine still hasn’t been approved by the European Medicines Agency (EMA) despite having been registered in 69 of the world's countries to date, including EU members Hungary and Slovakia. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |